Atractylenolide I inhibits lipopolysaccharide-induced inflammatory responses via mitogen-activated protein kinase pathways in RAW264.7 cells

Immunopharmacology and Immunotoxicology

Volumn 36, Issue 6, 2014, Pages 420-425

  Ji, Guangquan ^a   Chen, Renqiong ^b   Zheng, Jianxian ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atractylenolide I; Macrophage; MAPK; NF B; Tumor necrosis factor alpha

Indexed keywords

ANTIINFLAMMATORY AGENT; ATRACTYLENOLIDE I; ATRACTYLODIS MACROCEPHALAE EXTRACT; BIOLOGICAL FACTOR; CD14 ANTIGEN; COMPLEMENT RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; MYELOID DIFFERENTIATION PROTEIN 2; PLANT EXTRACT; SCAVENGER RECEPTOR A; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATRACTYLODIS MACROCEPHALAE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MEDICINAL PLANT; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 84964310892     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2014.968256     Document Type: Article

References (37)

1. Arenzana-Seisdedos F, Virelizier JL. Interferons as macrophageactivating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes. Eur J Immunol 1983;13:437-440
2. Mongan LC, Jones T, Patrick G. Cytokine and free radical responses of alveolar macrophages in vitro to asbestos fibres. Cytokine 2000;12:1243-1247
3. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997;112: 321S-329S.
4. Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov 2003;2:736-746
5. Ajizian SJ, English BK, Meals EA. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 1999; 179:939-944
6. Akashi S, Shimazu R, Ogata H, et al. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000;164:3471-3475
7. Yu H, Ha T, Liu L, et al. Scavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-kB activation in macrophages. Biochim Biophys Acta 2012;1823:1192-1198
8. Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003;74:479-485
9. Natoli G, Chiocca S. Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation. Sci Signal 2008; 1:pe1
10. Zhao Q, Shepherd EG, Manson ME, et al. The role of mitogenactivated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem 2005;280:8101-8108
11. Ivashkiv LB. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur J Immunol 2011;41:2477-2481
12. Peng W, Han T, Xin WB, et al. Comparative research of chemical constituents and bioactivities between petroleum ether extracts of the aerial part and the rhizome of Atractylodes macrocephala. Med Chem Res 2011;20:146-151
13. Endo K, Taguchi T, Taguchi F, et al. Antiinflammatory principles of Atractylodes rhizomes. Chem Pharm Bull (Tokyo) 1979;27: 2954-2958
14. Sin KS, Kim HP, Lee WC, Pachaly P. Pharmacological activities of the constituents of Atractylodes rhizomes. Arch Pharm Res 1989; 12:236-238
15. Yang HJ, Jang DJ, Hwang JT. Anti-diabetic effects of Korean red pepper via MPK and PPAR-g activation in C2C12 myotubes. J Funct Foods 2012;4:552-558
16. Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci U S A 1995;92:12230-12234
17. Beutler B, Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol 1989;7: 625-655
18. Aggarwal BB, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 1996;7:93-124
19. Roth J, Störr B, Voigt K, Zeisberger E. Inhibition of nitric oxide synthase attenuates lipopolysaccharide-induced fever without reduction of circulating cytokines in guinea-pigs. Pflugers Arch 1998;436:858-862
20. Li CQ, He LC, Jin JQ. Atractylenolide I and atractylenolide III inhibit Lipopolysaccharide-induced TNF-alpha and NO production in macrophages. Phytother Res 2007;21:347-353
21. Wang CH, Duan HJ, He LC. Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro. Eur J Pharmacol 2009;612:143-152
22. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94
23. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-142
24. Caivano M. Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett 1998;429:249-253
25. Vanden Berghe W, Plaisance S, Boone E, et al. p38 And extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 1998;273:3285-3290
26. Bayon Y, Ortiz MA, Lopez-Hernandez FJ, et al. Inhibition of IkappaB kinase by a new class of retinoid-related anticancer agents that induce apoptosis. Mol Cell Biol 2003;23:1061-1074
27. D'Acquisto F, May MJ, Ghosh S. Inhibition of nuclear factor kappa B (NF-kB): an emerging theme in anti-inflammatory therapies. Mol Interv 2002;2:22-35
28. Shin EM, Zhou HY, Guo LY, et al. Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264.7 macrophages. Int Immunopharmacol 2008;8: 1524-1532
29. Perera PY, Mayadas TN, Takeuchi O, et al. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 2001;166:574-581
30. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007;7: 353-364
31. O'Neill LA, Fitzgerald KA, Bowie AG. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 2003;24: 286-290
32. Oshikawa K, Sugiyama Y. Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem Biophys Res Commun 2003;305:649-655
33. Wu J, Zhang YY, Guo L, et al. Bupleurum polysaccharides attenuates lipopolysaccharide-induced inflammation via modulating Toll-like receptor 4 signaling. PLoS One 2013;8:e78051
34. Li CQ, He LC, Dong HY, Jin JQ. Screening for the antiinflammatory activity of fractions and compounds from Atractylodes macrocephala koidz. J Ethnopharmacol 2007;114: 212-217
35. Li C, He L. Establishment of the model of white blood cell membrane chromatography and screening of antagonizing TLR4 receptor component from Atractylodes macrocephala Koidz. Sci China C Life Sci 2006;49:182-189
36. Yuan BX, Hou J, He LC, Yang GD. Evaluation of drug-muscarinic receptor affinities using cell membrane chromatography and radioligand binding assay in guinea pig jejunum membrane. Acta Pharmacol Sin 2005;26:113-116
37. Huang JM, Zhang GN, Shi Y, et al. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. Sci Rep 2014;4:3840